Page last updated: 2024-09-03

glycylglutamine and 3,4-dihydroxyphenylacetic acid

glycylglutamine has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies

Compound Research Comparison

Studies
(glycylglutamine)
Trials
(glycylglutamine)
Recent Studies (post-2010)
(glycylglutamine)
Studies
(3,4-dihydroxyphenylacetic acid)
Trials
(3,4-dihydroxyphenylacetic acid)
Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid)
1048145,41038591

Protein Interaction Comparison

ProteinTaxonomyglycylglutamine (IC50)3,4-dihydroxyphenylacetic acid (IC50)
intestinal alkaline phosphatase precursorMus musculus (house mouse)4.17

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basaran, NF; Buyukuysal, RL; Cavun, S; Millington, WR1

Other Studies

1 other study(ies) available for glycylglutamine and 3,4-dihydroxyphenylacetic acid

ArticleYear
Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.
    Naunyn-Schmiedeberg's archives of pharmacology, 2010, Volume: 381, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Male; Microdialysis; Morphine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Time Factors

2010